| 存储条件 |
|---|
| Product Name | FN1 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | FN; CIG; FNZ; MSF; ED-B; FINC; GFND; LETS; GFND2 |
| Immunogen | Purified recombinant fragment of human FN1 expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Isotype | Unknown |
| Host Species | Unknow |
| Tested Applications | WBIHCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. | |
| Species Reactivity | Human |
| Purification | Unpurified |
| Alternative Names | FN CIG FNZ MSF ED-B FINC GFND LETS GFND2 |
|---|---|
| Molecular Weight(MW) | 262.6kDa |
| Entrez Gene | 2335 |
|---|
Application
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);
Application
Figure 1: Western blot analysis using FN1 mAb against human FN1 (AA: 1965-2176) recombinant protein. (Expected MW is 49.6 kDa)
Application
Figure 2: Western blot analysis using FN1 mAb against HEK293 (1) and FN1 (AA: 1965-2176)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 3: Immunohistochemical analysis of paraffin-embedded lung cancer tissues using FN1 mouse mAb with DAB staining.
Application
Figure 4: Immunohistochemical analysis of paraffin-embedded stomach cancer tissues using FN1 mouse mAb with DAB staining.
Application
Figure 5: Flow cytometric analysis of HeLa cells using FN1 mouse mAb (green) and negative control (red).| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
抱歉，暂无相关文献
